Advertisement
News
Advertisement

Navartis to Buy Ebewe Pharma's Injectable Unit

Wed, 05/20/2009 - 4:30am
Novartis AG has agreed to buy Ebewe Pharma’s injectables unit for 1.2 billion US dollars (925 million euros) in an all-cash transaction that will add generic cancer drugs to the Swiss company’s offerings. The takeover excludes Ebewe Pharma’s neurological products business, Basel-based Novartis said in a statement on Wednesday, May 20, 2009.

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading